
    
      A total of 60 male and female type 2 diabetic subjects will be recruited and randomized into
      1 of 3 treatment groups for the 4 months long trial

        1. ACTOS plus a standard diet

        2. ACTOS plus a portion-controlled diet

        3. Metformin plus a standard diet. The end-point of the trial is the change in body fat
           content from baseline to the end of the trial
    
  